Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
American Finance Trust Inc is a reit-diversified business based in the US. American Finance Trust shares (AFIN) are listed on the NASDAQ and all prices are listed in US Dollars.
|Latest market close||$8.60|
|52-week range||$4.89 - $9.95|
|50-day moving average||$8.44|
|200-day moving average||$8.85|
|Wall St. target price||$11.00|
|Dividend yield||$0.665 (7.84%)|
|Earnings per share (TTM)||$-0.30|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-15)||1.18%|
|1 month (2021-09-22)||3.37%|
|3 months (2021-07-22)||3.12%|
|6 months (2021-04-22)||-10.83%|
|1 year (2020-10-21)||43.33%|
|2 years (2019-10-21)||-40.48%|
|3 years (2018-10-19)||14.09|
|5 years (2016-10-18)||N/A|
Valuing American Finance Trust stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of American Finance Trust's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
American Finance Trust's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $191.2 million.
The EBITDA is a measure of a American Finance Trust's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$316.5 million|
|Operating margin TTM||18.76%|
|Gross profit TTM||$223 million|
|Return on assets TTM||1.02%|
|Return on equity TTM||-0.79%|
|Market capitalisation||$1 billion|
TTM: trailing 12 months
There are currently 2.2 million American Finance Trust shares held short by investors – that's known as American Finance Trust's "short interest". This figure is 18.4% up from 1.9 million last month.
There are a few different ways that this level of interest in shorting American Finance Trust shares can be evaluated.
American Finance Trust's "short interest ratio" (SIR) is the quantity of American Finance Trust shares currently shorted divided by the average quantity of American Finance Trust shares traded daily (recently around 1.2 million). American Finance Trust's SIR currently stands at 1.77. In other words for every 100,000 American Finance Trust shares traded daily on the market, roughly 1770 shares are currently held short.
However American Finance Trust's short interest can also be evaluated against the total number of American Finance Trust shares, or, against the total number of tradable American Finance Trust shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case American Finance Trust's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 American Finance Trust shares in existence, roughly 20 shares are currently held short) or 0.0188% of the tradable shares (for every 100,000 tradable American Finance Trust shares, roughly 19 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against American Finance Trust.
Find out more about how you can short American Finance Trust stock.
Dividend payout ratio: 93.41% of net profits
Recently American Finance Trust has paid out, on average, around 93.41% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 10.02% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), American Finance Trust shareholders could enjoy a 10.02% return on their shares, in the form of dividend payments. In American Finance Trust's case, that would currently equate to about $0.665 per share.
American Finance Trust's payout ratio would broadly be considered high, and as such this stock could appeal to those looking to generate an income. Bear in mind however that companies should normally also look to re-invest a decent amount of net profits to ensure future growth.
American Finance Trust's most recent dividend payout was on 14 October 2021. The latest dividend was paid out to all shareholders who bought their shares by 7 October 2021 (the "ex-dividend date").
Over the last 12 months, American Finance Trust's shares have ranged in value from as little as $4.8898 up to $9.945. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while American Finance Trust's is 1.3897. This would suggest that American Finance Trust's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
American Finance Trust, Inc. (Nasdaq: AFIN) is a publicly traded real estate investment trust listed on the Nasdaq focused on acquiring and managing a diversified portfolio of primarily service-oriented and traditional retail and distribution related commercial real estate properties in the U. S. .
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.